These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5420748)

  • 1. Oral contraceptives and serum lipids.
    Barton GM; Freeman PR; Lawson JP
    J Obstet Gynaecol Br Commonw; 1970 Jun; 77(6):551-4. PubMed ID: 5420748
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum-lipids in women on oral contraceptives.
    Stokes T; Wynn V
    Lancet; 1971 Sep; 2(7726):677-80. PubMed ID: 4105711
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications of oral contraceptive agents--a symposim. Contraceptives and lipid metabolism.
    Fiser RH
    West J Med; 1975 Jan; 122(1):35-8. PubMed ID: 162816
    [No Abstract]   [Full Text] [Related]  

  • 4. Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.
    Glueck CJ; Scheel D; Fishback J; Steiner P
    Lipids; 1972 Feb; 7(2):110-3. PubMed ID: 4551949
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contraceptive pills; their effect on lipid and carbohydrate metabolism and on the cardiocirculatory system. Epidemiological and experimental aspects].
    Lederer J; Vastesaeger M
    Brux Med; 1977 May; 57(5):199-214. PubMed ID: 880501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolism of circulating lipids in patients taking oral contraceptives].
    Turpin G; Menage JJ
    Sem Hop; 1973 Oct; 49(43):2833-8. PubMed ID: 4362577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Review of side effects of oral contraceptives].
    Janssens J
    Nature; 1970 Jul; 227(5256):1418-22. PubMed ID: 5448324
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of estrogens and progestogens on lipid metabolism.
    Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Pancreatitis from oral contraceptives.
    Br Med J; 1973 Dec; 4(5894):688-9. PubMed ID: 4776878
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Estrogens and gallstones.
    Grant N
    N Engl J Med; 1974 Apr; 290(16):912. PubMed ID: 4816973
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of steroids on serum lipids and serum cholesterol binding reserve.
    Roth MS; Donato DM; Lansman HH; Robertson EG; Hsia SL; LeMaire WJ
    Am J Obstet Gynecol; 1978 Sep; 132(2):151-6. PubMed ID: 686104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various possible adverse effects of synthetic estroprogestinic preparations at the extragenital level (review of the literature and personal contributions)].
    Lauro V
    Arch Ostet Ginecol; 1969; 74(3):193-235. PubMed ID: 5402696
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral contraception: uncertainties and prospects].
    Mauvais-Jarvis P
    Rev Prat; 1978 Sep; 28(41):3143-6, 3149-50, 3153-6. PubMed ID: 715351
    [No Abstract]   [Full Text] [Related]  

  • 17. Oestrogenic potency and oral contraceptives.
    Br Med J; 1975 Jun; 2(5972):651-2. PubMed ID: 1169999
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and cardiovascular disease (second of two parts).
    Stadel BV
    N Engl J Med; 1981 Sep; 305(12):672-7. PubMed ID: 7022211
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive hyperlipemia during estrogen therapy.
    Molitch ME; Oill P; Odell WD
    JAMA; 1974 Feb; 227(5):522-5. PubMed ID: 4358883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.